AstraZeneca PLC ADR AZN,
lost 1.41% to $ 50.19 on Thursday in what turned out to be an excellent stock trading session with the NASDAQ Composite Index COMP,
up 2.56% to 13,067.48 and Dow Jones Industrial Media DJIA,
increasing by 0.69% to 31,041.13. The fall of the ADR hit a three-day victory. AstraZeneca PLC ADR closed at $ 14.75 in addition to the 52-week high ($ 64.94), which the company reached on July 20.
ADR performed poorly compared to some of its competitors on Thursday, such as AbbVie Inc.
rose 1.07% to $ 106.71, Amgen Inc. AMGN,
increased 0.33% to $ 234.02, and Gilead Sciences Inc. GILD,
increased 0.92% to $ 62.52. Trading volume (13.6 M) overshadowed the 10-day average volume of 10.2 M.
Editor’s note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See the terms of use of our market data.